Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Vierling, JM
   Animal models for primary sclerosing cholangitis
   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
   
   J.M. Vierling, "Animal models for primary sclerosing cholangitis", BEST PR RES, 15(4), 2001, pp. 591-610
2. Kuwahara, H; Tani, Y; Ogawa, Y; Takaichi, Y; Shiraishi, A; Ohtsuki, M
   Therapeutic effect of novel anti-human Fas antibody HFE7A on graft-versus-host disease model
   CLINICAL IMMUNOLOGY
   
   H. Kuwahara et al., "Therapeutic effect of novel anti-human Fas antibody HFE7A on graft-versus-host disease model", CLIN IMMUNO, 99(3), 2001, pp. 340-346
3. Bhatia, V; Porter, DL
   Novel approaches to allogeneic stem cell therapy
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   V. Bhatia e D.L. Porter, "Novel approaches to allogeneic stem cell therapy", EXPERT OP B, 1(1), 2001, pp. 3-15
4. Perutelli, P; Murugesan, S; Dini, G
   Adhesion of MNC to extracellular matrix proteins following in vitro photochemotherapy
   CYTOTHERAPY
   
   P. Perutelli et al., "Adhesion of MNC to extracellular matrix proteins following in vitro photochemotherapy", CYTOTHERAPY, 3(1), 2001, pp. 31-36
5. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
   Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation
   INTERNAL MEDICINE JOURNAL
   
   A. Grigg et al., "Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation", INTERN M J, 31(1), 2001, pp. 15-22
6. Hromadnikova, I; Sedlacek, P; Stary, J; Cermakova, M; Vavrinec, J; Stechova, K; Dolezalova, L; Sviland, L; Dickinson, AM
   An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants
   PEDIATRIC TRANSPLANTATION
   
   I. Hromadnikova et al., "An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants", PEDIAT TRAN, 5(4), 2001, pp. 258-265
7. Simpson, D
   Tresperimus: a new agent for transplant tolerance induction
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   D. Simpson, "Tresperimus: a new agent for transplant tolerance induction", EXPERT OP I, 10(7), 2001, pp. 1381-1386
8. Gaziev, D; Lucarelli, G
   Novel approaches to the treatment of chronic graft-versus-host disease
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   D. Gaziev e G. Lucarelli, "Novel approaches to the treatment of chronic graft-versus-host disease", EXPERT OP I, 10(5), 2001, pp. 909-923
9. Trisolini, R; Stanzani, M; Agli, LL; Colangelo, A; Bonifazi, F; Falcioni, S; Patelli, M; Falcone, F; Bandini, G; Tura, S; Poletti, V
   Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients
   SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
   
   R. Trisolini et al., "Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients", SARCO VASC, 18(1), 2001, pp. 75-84
10. Peris-Martinez, C; Menezo, JL; Diaz-Llopis, M; Avino-Martinez, JA; Navea-Tejerina, A; Risueno-Reguillo, P
    Multilayer amniotic membrane transplantation in severe ocular graft versushost disease
    EUROPEAN JOURNAL OF OPHTHALMOLOGY
    
    C. Peris-Martinez et al., "Multilayer amniotic membrane transplantation in severe ocular graft versushost disease", EUR J OPTHA, 11(2), 2001, pp. 183-186
11. Auletta, JJ; Fisher, VL
    Immune reconstitution in pediatric stem-cell transplantation
    FRONTIERS IN BIOSCIENCE
    
    J.J. Auletta e V.L. Fisher, "Immune reconstitution in pediatric stem-cell transplantation", FRONT BIOSC, 6, 2001, pp. G23-G32
12. Scheimberg, I; Hoeger, PH; Harper, JI; Lake, B; Malone, M
    Omenn's syndrome: Differential diagnosis in infants with erythroderma and immunodeficiency
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
    
    I. Scheimberg et al., "Omenn's syndrome: Differential diagnosis in infants with erythroderma and immunodeficiency", PEDIATR D P, 4(3), 2001, pp. 237-245
13. Akpek, G; Lee, SM; Anders, V; Vogelsang, GB
    A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    G. Akpek et al., "A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease", BIOL BLOOD, 7(9), 2001, pp. 495-502
14. Grumet, FC; Hiraki, DD; Brown, BW; Zehnder, JL; Zacks, ES; Draksharapu, A; Parnes, J; Negrin, RS
    CD31 mismatching affects marrow transplantation outcome
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    F.C. Grumet et al., "CD31 mismatching affects marrow transplantation outcome", BIOL BLOOD, 7(9), 2001, pp. 503-512
15. Khan, SA; Gaa, B; Pollock, BH; Shea, B; Reddy, V; Wingard, YR; Moreb, JS
    Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    S.A. Khan et al., "Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival", BIOL BLOOD, 7(8), 2001, pp. 433-438
16. Arora, M; Wagner, JE; Davies, SM; Blazar, BR; Defor, T; Enright, H; Miller, WF; Weisdorf, DJ
    Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    M. Arora et al., "Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease", BIOL BLOOD, 7(5), 2001, pp. 265-273
17. Patterson, AE; Korngold, R
    Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    A.E. Patterson e R. Korngold, "Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation", BIOL BLOOD, 7(4), 2001, pp. 187-196
18. Blazar, BR; McKenna, HJ; Panoskaltsis-Mortari, A; Taylor, PA
    Flt3 ligand (FL) treatment of murine donors does not modify graft-versus host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    B.R. Blazar et al., "Flt3 ligand (FL) treatment of murine donors does not modify graft-versus host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality", BIOL BLOOD, 7(4), 2001, pp. 197-207
19. Bruno, B; Gooley, T; Sullivan, KM; Davis, C; Bensinger, WI; Storb, R; Nash, RA
    Secondary failure of platelet recovery after hematopoietic stem cell transplantation
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    B. Bruno et al., "Secondary failure of platelet recovery after hematopoietic stem cell transplantation", BIOL BLOOD, 7(3), 2001, pp. 154-162
20. Johnson, BD; Dagher, N; Stankowski, MC; Hanke, CA; Truitt, RL
    Donor natural killer (NK1.1(+)) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    B.D. Johnson et al., "Donor natural killer (NK1.1(+)) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI", BIOL BLOOD, 7(11), 2001, pp. 589-595
21. Keever-Taylor, CA; Bredeson, C; Loberiza, FR; Casper, JT; Lawton, C; Rizzo, D; Burns, WH; Margolis, DA; Vesole, DH; Horowitz, M; Zhang, MJ; Juckett, M; Drobyski, WR
    Analysis of risk factors for the development of GVHD after T cell-depletedallogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    C.A. Keever-Taylor et al., "Analysis of risk factors for the development of GVHD after T cell-depletedallogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion", BIOL BLOOD, 7(11), 2001, pp. 620-630
22. Shimoni, A; Gajewski, J; Donato, M; Martin, T; O'Brien, S; Talpaz, M; Cohen, A; Korbling, M; Champlin, R; Giralt, S
    Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    A. Shimoni et al., "Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation", BIOL BLOOD, 7(10), 2001, pp. 568-575
23. Friedman, TM; Statton, D; Jones, SC; Berger, MA; Murphy, GF; Korngold, R
    V beta spectratype analysis reveals heterogeneity of CD4(+) T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: Correlations with epithelial tissue infiltrate
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    T.M. Friedman et al., "V beta spectratype analysis reveals heterogeneity of CD4(+) T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: Correlations with epithelial tissue infiltrate", BIOL BLOOD, 7(1), 2001, pp. 2-13
24. Correia, O; Delgado, L; Barbosa, IL; Domingues, JC; Azevedo, R; Vaz, CP; Pimentel, P
    CD8+lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: Further similarities with toxic epidermal necrolysis
    DERMATOLOGY
    
    O. Correia et al., "CD8+lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: Further similarities with toxic epidermal necrolysis", DERMATOLOGY, 203(3), 2001, pp. 212-216
25. Higaki, Y; Yamada, O; Okamura, T; Mizoguchi, H; Kawashima, M
    Granzyme-B-containing lymphocyte involvement in epidermal injury in graft-versus-host disease
    DERMATOLOGY
    
    Y. Higaki et al., "Granzyme-B-containing lymphocyte involvement in epidermal injury in graft-versus-host disease", DERMATOLOGY, 202(2), 2001, pp. 94-98
26. Field, EH; Strober, S
    Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    
    E.H. Field e S. Strober, "Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation", PHI T ROY B, 356(1409), 2001, pp. 739-748
27. Kumar, S; Tefferi, A
    Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation - case report and review of literature
    ANNALS OF HEMATOLOGY
    
    S. Kumar e A. Tefferi, "Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation - case report and review of literature", ANN HEMATOL, 80(7), 2001, pp. 430-435
28. Kroger, N; Zabelina, T; Kruger, W; Renges, H; Stute, N; Durken, M; von Finkenstein, FG; Erttmann, R; Kabisch, H; Schafhausen, P; Jaburg, N; Loliger, C; Zander, AR
    Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors
    ANNALS OF HEMATOLOGY
    
    N. Kroger et al., "Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors", ANN HEMATOL, 80(4), 2001, pp. 209-215
29. Mori, A; Hashino, S; Kobayashi, S; Tanaka, J; Yamamoto, Y; Asaka, M; Imamura, M
    Avascular necrosis in the femoral head secondary to bone marrow infarctionin a patient with graft-versus-host disease after unrelated bone marrow transplantation
    ANNALS OF HEMATOLOGY
    
    A. Mori et al., "Avascular necrosis in the femoral head secondary to bone marrow infarctionin a patient with graft-versus-host disease after unrelated bone marrow transplantation", ANN HEMATOL, 80(4), 2001, pp. 238-242
30. Kanamori, H; Mishima, A; Tanaka, M; Yamaji, S; Fujisawa, S; Koharazawa, H; Nishikawa, M; Matsuzaki, M; Mohri, H; Ishigatsubo, Y
    Bronchiolitis obliterans organizing pneumonia (BOOP) with suspected liver graft-versus-host disease after allogeneic bone marrow transplantation
    TRANSPLANT INTERNATIONAL
    
    H. Kanamori et al., "Bronchiolitis obliterans organizing pneumonia (BOOP) with suspected liver graft-versus-host disease after allogeneic bone marrow transplantation", TRANSPLAN I, 14(4), 2001, pp. 266-269
31. Tomonari, A; Tojo, A; Iseki, T; Ooi, J; Nagayama, H; Ogami, K; Maekawa, T; Shirafuji, N; Tani, K; Asano, S
    Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    A. Tomonari et al., "Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia", INT J HEMAT, 74(2), 2001, pp. 228-232
32. El Marsafy, S; Dosquet, C; Coudert, MC; Bensussan, A; Carosella, E; Gluckman, E
    Study of cord blood natural killer cell suppressor activity
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    S. El Marsafy et al., "Study of cord blood natural killer cell suppressor activity", EUR J HAEMA, 66(4), 2001, pp. 215-220
33. Varis, I; Deneys, V; Mazzon, AM; De Bruyere, M; Cornu, G; Brichard, B
    Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    I. Varis et al., "Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes", EUR J HAEMA, 66(2), 2001, pp. 107-114
34. Remberger, M; Aschan, J; Lonnqvist, B; Carlens, S; Gustafsson, B; Hentschke, P; Klaesson, S; Mattsson, J; Ljungman, P; Ringden, O
    An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    M. Remberger et al., "An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation", EUR J HAEMA, 66(1), 2001, pp. 50-56
35. Huang, XJ; Wan, J; Lu, DP
    Serum TNF alpha levels in patients with acute graft-versus-host disease after bone marrow transplantation
    LEUKEMIA
    
    X.J. Huang et al., "Serum TNF alpha levels in patients with acute graft-versus-host disease after bone marrow transplantation", LEUKEMIA, 15(7), 2001, pp. 1089-1091
36. Karrer, S; Holler, E; Szeimies, RM
    Cutaneous manifestations of graft-versus-host disease
    MEDIZINISCHE KLINIK
    
    S. Karrer et al., "Cutaneous manifestations of graft-versus-host disease", MED KLIN, 96(8), 2001, pp. 457-466
37. Choi, ICY; Fung, PCW; Leung, AYH; Lie, AKW; Liang, R
    Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in hemopoietic stem cell transplant recipients
    HAEMATOLOGICA
    
    I.C.Y. Choi et al., "Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in hemopoietic stem cell transplant recipients", HAEMATOLOG, 86(9), 2001, pp. 972-976
38. Leung, AYH; Kwok, J; Lie, AKW; Chen, P; Chen, FE; Liang, R
    Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings
    HAEMATOLOGICA
    
    A.Y.H. Leung et al., "Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings", HAEMATOLOG, 86(6), 2001, pp. 652-656
39. Dotti, G; Gaspari, F; Caruso, R; Perico, N; Remuzzi, G; Barbui, T; Rambaldi, A
    Pharmacokinetic study of the new cyclosporin-A formulation (Neoral (TM)) in adult allogeneic bone marrow transplant recipients
    HAEMATOLOGICA
    
    G. Dotti et al., "Pharmacokinetic study of the new cyclosporin-A formulation (Neoral (TM)) in adult allogeneic bone marrow transplant recipients", HAEMATOLOG, 86(3), 2001, pp. 311-315
40. Matsubara, H; Makimoto, A; Takayama, J; Higa, T; Saito, T; Kanda, Y; Tanosaki, R; Mineishi, S; Ohira, M; Takaue, Y
    Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    H. Matsubara et al., "Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia", JPN J CLIN, 31(1), 2001, pp. 30-34
41. Liu, HZ; Mao, N; Hou, CM; Li, XS; Shen, BF; Tang, PH
    Protective effect of human CD40-Ig fusion protein in a murine model of acute graft-versus-host disease
    CHINESE MEDICAL JOURNAL
    
    H.Z. Liu et al., "Protective effect of human CD40-Ig fusion protein in a murine model of acute graft-versus-host disease", CHIN MED J, 114(7), 2001, pp. 685-689
42. Li, YQ; Du, X; Xu, MH; Zhang, T; Yang, LJ; Chen, SH
    Stable clonal expansion of the T-cell receptor V beta 6, V beta 17 and V beta 19 T cells in a cGVHD case using genescan analysis
    CHINESE MEDICAL JOURNAL
    
    Y.Q. Li et al., "Stable clonal expansion of the T-cell receptor V beta 6, V beta 17 and V beta 19 T cells in a cGVHD case using genescan analysis", CHIN MED J, 114(5), 2001, pp. 489-492
43. Yurovsky, VV; Cottler-Fox, MH; Atamas, SP; Shanholtz, CB; Britt, EJ; Sensenbrenner, LL; White, B
    Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation
    AMERICAN JOURNAL OF HEMATOLOGY
    
    V.V. Yurovsky et al., "Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation", AM J HEMAT, 66(1), 2001, pp. 1-11
44. Deguchi, M; Ohtani, H; Sato, E; Naito, Y; Nagura, H; Aiba, S; Tagami, H
    Proliferative activity of CD8(+) T cells as an important clue to analyze Tcell-mediated inflammatory dermatoses
    ARCHIVES OF DERMATOLOGICAL RESEARCH
    
    M. Deguchi et al., "Proliferative activity of CD8(+) T cells as an important clue to analyze Tcell-mediated inflammatory dermatoses", ARCH DERM R, 293(9), 2001, pp. 442-447
45. Hattori, M; Morita, N; Tsujino, Y; Yamamoto, M; Tanizawa, T
    Vitamins D and K in the treatment of osteoporosis secondary to graft-versus-host disease following bone-marrow transplantation
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    M. Hattori et al., "Vitamins D and K in the treatment of osteoporosis secondary to graft-versus-host disease following bone-marrow transplantation", J INT MED R, 29(4), 2001, pp. 381-384
46. Ogawa, Y; Okamoto, S; Kuwana, M; Mori, T; Watanabe, R; Nakajima, T; Yamada, M; Mashima, Y; Tsubota, K; Oguchi, Y
    Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids
    CORNEA
    
    Y. Ogawa et al., "Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids", CORNEA, 20(4), 2001, pp. 430-434
47. Le Blanc, R; Montminy-Metivier, S; Belanger, R; Busque, L; Fish, D; Roy, DC; Kassis, J; Boileau, J; Lavallee, R; Belanger, D; Letendre, F; Hebert, J; Sauvageau, G; Perreault, C; Roy, J
    Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect
    BONE MARROW TRANSPLANTATION
    
    R. Le Blanc et al., "Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect", BONE MAR TR, 28(9), 2001, pp. 841-848
48. Amrolia, PJ; Rao, K; Slater, O; Ramsay, A; Veys, PA; Webb, DKH
    Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion
    BONE MARROW TRANSPLANTATION
    
    P.J. Amrolia et al., "Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion", BONE MAR TR, 28(6), 2001, pp. 623-625
49. Denianke, KS; Frieden, IJ; Cowan, MJ; Williams, ML; McCalmont, TH
    Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic study
    BONE MARROW TRANSPLANTATION
    
    K.S. Denianke et al., "Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic study", BONE MAR TR, 28(3), 2001, pp. 227-233
50. Fallows, G; Rubinger, M; Bernstein, CN
    Does gastroenterology consultation change management of patients receivinghematopoietic stem cell transplantation?
    BONE MARROW TRANSPLANTATION
    
    G. Fallows et al., "Does gastroenterology consultation change management of patients receivinghematopoietic stem cell transplantation?", BONE MAR TR, 28(3), 2001, pp. 289-294
51. Ratanatharathorn, V; Ayash, L; Lazarus, HM; Fu, J; Uberti, JP
    Chronic graft-versus-host disease: clinical manifestation and therapy
    BONE MARROW TRANSPLANTATION
    
    V. Ratanatharathorn et al., "Chronic graft-versus-host disease: clinical manifestation and therapy", BONE MAR TR, 28(2), 2001, pp. 121-129
52. Winston, DJ; Antin, JH; Wolff, SN; Bierer, BE; Small, T; Miller, KB; Linker, C; Kaizer, H; Lazarus, HM; Petersen, FB; Cowan, MJ; Ho, WG; Wingard, JR; Schiller, GJ; Territo, MC; Jiao, J; Petrarca, MA; Tonetta, SA
    A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    D.J. Winston et al., "A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation", BONE MAR TR, 28(2), 2001, pp. 187-196
53. Okamoto, T; Takatsuka, H; Fujimori, Y; Wada, H; Iwasaki, T; Kakishita, E
    Increased hepatocyte growth factor in serum in acute graft-versus-host disease
    BONE MARROW TRANSPLANTATION
    
    T. Okamoto et al., "Increased hepatocyte growth factor in serum in acute graft-versus-host disease", BONE MAR TR, 28(2), 2001, pp. 197-200
54. Hsu, B; May, R; Carrum, G; Krance, R; Przepiorka, D
    Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey
    BONE MARROW TRANSPLANTATION
    
    B. Hsu et al., "Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey", BONE MAR TR, 28(10), 2001, pp. 945-950
55. Nivison-Smith, I; Bradstock, KF; Szer, J; Durrant, S; Dodds, A; Hermann, R; Schwarer, AP; Gibson, J; To, LB; Arthur, C
    Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow
    BONE MARROW TRANSPLANTATION
    
    I. Nivison-Smith et al., "Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow", BONE MAR TR, 28(1), 2001, pp. 21-27
56. Ancin, I; Ferra, C; Gallardo, D; Peris, J; Berlanga, J; Gonzalez, JR; Virgili, N; Granena, A
    Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
    BONE MARROW TRANSPLANTATION
    
    I. Ancin et al., "Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?", BONE MAR TR, 28(1), 2001, pp. 39-45
57. Kobbe, G; Schneider, P; Rohr, U; Fenk, R; Neumann, F; Aivado, M; Dietze, L; Kronenwett, R; Hunerliturkoglu, A; Haas, R
    Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNF alpha antibody
    BONE MARROW TRANSPLANTATION
    
    G. Kobbe et al., "Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNF alpha antibody", BONE MAR TR, 28(1), 2001, pp. 47-49
58. Yoshikawa, T; Ihira, M; Ohashi, M; Suga, S; Asano, Y; Miyazaki, H; Hirano, M; Suzuki, K; Matsunaga, K; Horibe, K; Kojima, S; Kudo, K; Kato, K; Matsuyama, T; Nishiyama, Y
    Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    T. Yoshikawa et al., "Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation", BONE MAR TR, 28(1), 2001, pp. 77-81
59. Russell, CA; Heilmann, C; Madsen, HO; Vindelov, LL
    The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bonemarrow transplantation
    BONE MARROW TRANSPLANTATION
    
    C.A. Russell et al., "The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bonemarrow transplantation", BONE MAR TR, 27(9), 2001, pp. 949-958
60. Fujii, N; Takenaka, K; Shinagawa, K; Ikeda, K; Maeda, Y; Sunami, K; Hiramatsu, Y; Matsuo, K; Ishimaru, F; Niiya, K; Yoshino, T; Hirabayashi, N; Harada, M
    Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation
    BONE MARROW TRANSPLANTATION
    
    N. Fujii et al., "Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation", BONE MAR TR, 27(9), 2001, pp. 1007-1010
61. Brentjens, RJ; Smith, L; Reich, L; Jakubowski, AA
    Development of spontaneous factor VIII inhibitor in association with acutegraft-versus-host disease
    BONE MARROW TRANSPLANTATION
    
    R.J. Brentjens et al., "Development of spontaneous factor VIII inhibitor in association with acutegraft-versus-host disease", BONE MAR TR, 27(8), 2001, pp. 887-889
62. Lysak, D; Koza, V; Jindra, P; Vozobulova, V; Schutzova, M; Fiser, J; Cerna, K; Karas, M; Skopek, P; Svojgrova, M; Vokurka, S
    Allogeneic BMT in patients above 45 years of age: a single center experience
    BONE MARROW TRANSPLANTATION
    
    D. Lysak et al., "Allogeneic BMT in patients above 45 years of age: a single center experience", BONE MAR TR, 27(7), 2001, pp. 723-726
63. Lamb, LS; Musk, P; Ye, Z; van Rhee, F; Geier, SS; Tong, JJ; King, KM; Henslee-Downey, PJ
    Human gamma delta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response
    BONE MARROW TRANSPLANTATION
    
    L.S. Lamb et al., "Human gamma delta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response", BONE MAR TR, 27(6), 2001, pp. 601-606
64. Hale, GA; Tong, X; Benaim, E; Cunningham, JM; Heslop, HE; Horwitz, EM; Leung, W; Rochester, RJ; Shearer, PD; Srivastava, DK; Woodard, JP; Bowman, LC
    Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    G.A. Hale et al., "Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation", BONE MAR TR, 27(2), 2001, pp. 155-162
65. Kindler, T; Schindel, C; Brass, U; Fischer, T
    Fatal sepsis due to Mycobacterium tuberculosis after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    T. Kindler et al., "Fatal sepsis due to Mycobacterium tuberculosis after allogeneic bone marrow transplantation", BONE MAR TR, 27(2), 2001, pp. 217-218
66. Silberstein, L; Davies, A; Kelsey, S; Foran, J; Murrell, C; D'Cruz, D; Vinnicombe, S; Norton, A; Cavenagh, J
    Myositis, polyserositis with a large pericardial effusion and constrictivepericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donorlymphocyte infusion
    BONE MARROW TRANSPLANTATION
    
    L. Silberstein et al., "Myositis, polyserositis with a large pericardial effusion and constrictivepericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donorlymphocyte infusion", BONE MAR TR, 27(2), 2001, pp. 231-233
67. Vogelsang, GB; Arai, S
    Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings
    BONE MARROW TRANSPLANTATION
    
    G.B. Vogelsang e S. Arai, "Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings", BONE MAR TR, 27(12), 2001, pp. 1255-1262
68. Ku, SC; Tang, JL; Hsueh, PR; Luh, KT; Yu, CJ; Yang, PC
    Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation
    BONE MARROW TRANSPLANTATION
    
    S.C. Ku et al., "Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation", BONE MAR TR, 27(12), 2001, pp. 1293-1297
69. Au, WY; Ho, JC; Lie, AK; Sun, J; Zheng, L; Liang, R; Lam, WK; Tsang, KW
    Respiratory ciliary function in bone marrow recipients
    BONE MARROW TRANSPLANTATION
    
    W.Y. Au et al., "Respiratory ciliary function in bone marrow recipients", BONE MAR TR, 27(11), 2001, pp. 1147-1151
70. Sakata, N; Yasui, M; Okamura, T; Inoue, M; Yumura-Yagi, K; Kawa, K
    Kinetics of plasma cytokines after hematopoietic stem cell transplantationfrom unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease
    BONE MARROW TRANSPLANTATION
    
    N. Sakata et al., "Kinetics of plasma cytokines after hematopoietic stem cell transplantationfrom unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease", BONE MAR TR, 27(11), 2001, pp. 1153-1161
71. Barge, RMY; Brouwer, RE; Beersma, MFC; Starrenburg, CWJ; Zwinderman, AH; Hale, G; Waldmann, H; den Ottolander, GJ; Falkenburg, JHF; Willemze, R; Fibbe, WE
    Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome
    BONE MARROW TRANSPLANTATION
    
    R.M.Y. Barge et al., "Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome", BONE MAR TR, 27(10), 2001, pp. 1053-1058
72. Gaziev, D; Lucarelli, G; Polchi, P; Angelucci, E; Galimberti, M; Giardini, C; Baronciani, D; Erer, B; Sodani, P
    A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease
    BONE MARROW TRANSPLANTATION
    
    D. Gaziev et al., "A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease", BONE MAR TR, 27(1), 2001, pp. 45-51
73. Lin, J; Markowtiz, GS; Nicolaides, M; Hesdorffer, CS; Appel, GB; D'Agati, VD; Savage, DG
    Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation - Report of 2 cases and review of the literature
    AMERICAN JOURNAL OF NEPHROLOGY
    
    J. Lin et al., "Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation - Report of 2 cases and review of the literature", AM J NEPHR, 21(5), 2001, pp. 351-356
74. Toubert, A; Charron, D
    Immune reconstitution after hematopoietic stem cell transplantation: Gaining experience without losing naivety
    HUMAN IMMUNOLOGY
    
    A. Toubert e D. Charron, "Immune reconstitution after hematopoietic stem cell transplantation: Gaining experience without losing naivety", HUMAN IMMUN, 62(5), 2001, pp. 500-503
75. Sviland, L; Hromadnikova, I; Sedlacek, P; Cermakova, M; Stechova, K; Holler, E; Eissner, G; Schulz, U; Kolb, HJ; Jackson, G; Wang, XN; Dickinson, AM
    Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation
    HUMAN IMMUNOLOGY
    
    L. Sviland et al., "Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation", HUMAN IMMUN, 62(11), 2001, pp. 1277-1281
76. Stuber, E; Schlenger, P; von Freier, A; Arendt, T; Folsch, UR
    Interferon-gamma is not involved in the intestinal manifestations of the acute murine semiallogenic graft-versus-host disease
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
    
    E. Stuber et al., "Interferon-gamma is not involved in the intestinal manifestations of the acute murine semiallogenic graft-versus-host disease", INT J COL R, 16(5), 2001, pp. 346-351
77. Stephenson, AL; Mackenzie, IRA; Levy, RD; Road, J
    Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness
    THORAX
    
    A.L. Stephenson et al., "Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness", THORAX, 56(1), 2001, pp. 82-84
78. Moriyama, S; Kurihara, K; Yokokawa, N; Satake, M; Juji, T
    Evaluation of absorbed dose-distribution in the X-ray or gamma-irradiator for blood products
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    
    S. Moriyama et al., "Evaluation of absorbed dose-distribution in the X-ray or gamma-irradiator for blood products", YAKUGAKU ZA, 121(4), 2001, pp. 283-288
79. Rossi, L; Cardarelli, F; Vampa, ML; Buzio, C; Olivetti, G
    Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma
    NEPHRON
    
    L. Rossi et al., "Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma", NEPHRON, 88(3), 2001, pp. 260-263
80. Brickner, AG; Warren, EH; Caldwell, JA; Akatsuka, Y; Golovina, TN; Zarling, AL; Shabanowitz, J; Eisenlohr, LC; Hunt, DF; Engelhard, VH; Riddell, SR
    The immunogenicity of a new human minor histocompatibility antigen resultsfrom differential antigen processing
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    A.G. Brickner et al., "The immunogenicity of a new human minor histocompatibility antigen resultsfrom differential antigen processing", J EXP MED, 193(2), 2001, pp. 195-205
81. Kadowaki, N; Antonenko, S; Ho, S; Rissoan, MC; Soumelis, V; Porcelli, SA; Lanier, LL; Liu, YJ
    Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    N. Kadowaki et al., "Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells", J EXP MED, 193(10), 2001, pp. 1221-1226
82. Hows, JM
    Status of umbilical cord blood transplantation in the year 2001
    JOURNAL OF CLINICAL PATHOLOGY
    
    J.M. Hows, "Status of umbilical cord blood transplantation in the year 2001", J CLIN PATH, 54(6), 2001, pp. 428-434
83. Caccavelli, L; Field, AC; Betin, V; Dreillard, L; Belair, MF; Bloch, MF; Bruneval, P; Kazatchkine, M; Bellon, B
    Normal IgG protects against acute graft-versus-host disease by targeting CD4(+)CD134(+) donor alloreactive T cells
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    L. Caccavelli et al., "Normal IgG protects against acute graft-versus-host disease by targeting CD4(+)CD134(+) donor alloreactive T cells", EUR J IMMUN, 31(9), 2001, pp. 2781-2790
84. Chiriva-Internati, M; Wang, ZQ; Xue, YY; Bumm, K; Hahn, AB; Lim, SH
    Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    M. Chiriva-Internati et al., "Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk", EUR J IMMUN, 31(8), 2001, pp. 2277-2283
85. Takenaka, K; Fujiyama, Y; Andoh, A; Sasaki, T; Amakata, Y; Matsubara, H; Hodohara, K; Bamba, T
    Prevention of murine acute graft-versus-host disease by staphylococcalenterotoxin B treatment
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    K. Takenaka et al., "Prevention of murine acute graft-versus-host disease by staphylococcalenterotoxin B treatment", CLIN EXP IM, 123(1), 2001, pp. 155-161
86. Gillis, TA; Donovan, ES
    Rehabilitation following bone marrow transplantation
    CANCER
    
    T.A. Gillis e E.S. Donovan, "Rehabilitation following bone marrow transplantation", CANCER, 92(4), 2001, pp. 998-1007
87. Cao, TM; Kusnierz-Glaz, C; Valone, F; Stockerl-Goldstein, KE; Hu, WW; Johnston, L; Blume, KG; Strober, S; Negrin, RS
    Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies
    CANCER
    
    T.M. Cao et al., "Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies", CANCER, 91(12), 2001, pp. 2205-2213
88. Gallardo, D; Arostegui, JI; Balas, A; Torres, A; Caballero, D; Carreras, E; Brunet, S; Jimenez, A; Mataix, R; Serrano, D; Vallejo, C; Sanz, G; Solano, C; Rodriguez-Luaces, M; Marin, J; Baro, J; Sanz, C; Roman, J; Gonzalez, M; Martorell, J; Sierra, J; Martin, C; de la Camara, R; Granena, A
    Disparity for the minor histocompatibility antigen HA-1 is associated withan increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation
    BRITISH JOURNAL OF HAEMATOLOGY
    
    D. Gallardo et al., "Disparity for the minor histocompatibility antigen HA-1 is associated withan increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation", BR J HAEM, 114(4), 2001, pp. 931-936
89. Balduini, CL; Frassoni, F; Noris, P; Klersy, C; Iannone, AM; Bacigalupo, A; Giorgiani, G; Di Pumpo, M; Locatelli, F
    Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor
    BRITISH JOURNAL OF HAEMATOLOGY
    
    C.L. Balduini et al., "Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor", BR J HAEM, 114(4), 2001, pp. 951-953
90. van der Straaten, HM; Fijnheer, R; Dekker, AW; Nieuwenhuis, HK; Verdonck, LF
    Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation
    BRITISH JOURNAL OF HAEMATOLOGY
    
    H.M. van der Straaten et al., "Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation", BR J HAEM, 114(1), 2001, pp. 31-35
91. Al-Ghamdi, H; Leisenring, W; Bensinger, WI; Nash, RA; Storb, R; Appelbaum, FR; Martin, PJ
    A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest
    BRITISH JOURNAL OF HAEMATOLOGY
    
    H. Al-Ghamdi et al., "A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest", BR J HAEM, 113(2), 2001, pp. 461-469
92. Willenbacher, W; Basara, N; Blau, IW; Fauser, AA; Kiehl, MG
    Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    BRITISH JOURNAL OF HAEMATOLOGY
    
    W. Willenbacher et al., "Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab", BR J HAEM, 112(3), 2001, pp. 820-823
93. Dominietto, A; Raiola, AM; van Lint, MT; Lamparelli, T; Gualandi, F; Berisso, G; Bregante, S; Frassoni, F; Casarino, L; Verdiani, S; Bacigalupo, A
    Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A. Dominietto et al., "Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose", BR J HAEM, 112(1), 2001, pp. 219-227
94. Brazzelli, V; Ardigo, M; Chiesa, MG; Vassallo, C; Varettoni, M; Borroni, RG; Alessandrino, EP; Borroni, G
    Flexural erythematous eruption following autologous peripheral blood stem cell transplantation: a study of four cases
    BRITISH JOURNAL OF DERMATOLOGY
    
    V. Brazzelli et al., "Flexural erythematous eruption following autologous peripheral blood stem cell transplantation: a study of four cases", BR J DERM, 145(3), 2001, pp. 490-495
95. Nagler, RM; Nagler, A
    The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease
    ARCHIVES OF ORAL BIOLOGY
    
    R.M. Nagler e A. Nagler, "The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease", ARCH ORAL B, 46(8), 2001, pp. 689-695
96. Tanaka, J; Tutumi, Y; Zhang, L; Mori, A; Kahata, K; Toyoshima, N; Ohta, S; Kobayashi, S; Hashino, S; Asaka, M; Imamura, M
    Increased proportion of HLA-class-I-specific natural killer cell receptors(CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation
    ACTA HAEMATOLOGICA
    
    J. Tanaka et al., "Increased proportion of HLA-class-I-specific natural killer cell receptors(CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation", ACT HAEMAT, 105(2), 2001, pp. 89-91
97. Proujansky, R
    Therapeutic approaches to gastrointestinal viral infection of the pediatric bone marrow transplant patient
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    
    R. Proujansky, "Therapeutic approaches to gastrointestinal viral infection of the pediatric bone marrow transplant patient", PEDIAT PATH, 19(2-3), 2000, pp. 179-185
98. Navarrete, CV
    The HLA system in blood transfusion
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    C.V. Navarrete, "The HLA system in blood transfusion", BEST P R C, 13(4), 2000, pp. 511-532
99. Lee, JH; Klein, HG
    From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    J.H. Lee e H.G. Klein, "From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes", BEST P R C, 13(4), 2000, pp. 585-600
100. Allen, RD; Slayback, DL; Harper, JM; Aguirre, TL; Dobkins, JA
     A locus closely linked to Mtv7 on mouse chromosome 1 influences development of acute versus chronic graft-versus-host disease in a murine model
     CLINICAL IMMUNOLOGY
     
     R.D. Allen et al., "A locus closely linked to Mtv7 on mouse chromosome 1 influences development of acute versus chronic graft-versus-host disease in a murine model", CLIN IMMUNO, 95(1), 2000, pp. 9-19